These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27090681)

  • 21. Shorter treatments for hepatitis C: another step forward?
    Foster GR
    Lancet; 2015 Mar; 385(9973):1054-5. PubMed ID: 25591504
    [No Abstract]   [Full Text] [Related]  

  • 22. Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
    Tong Y; Song YK; Tyring S
    JAMA Dermatol; 2016 Dec; 152(12):1393-1395. PubMed ID: 27732687
    [No Abstract]   [Full Text] [Related]  

  • 23. Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment.
    Gentile I; Borgia G
    Evid Based Med; 2014 Dec; 19(6):223-4. PubMed ID: 25028605
    [No Abstract]   [Full Text] [Related]  

  • 24. Harvoni (ledipasvir and sofosbuvir) for hepatitis C.
    Mullins C; Gibson W; Klibanov OM
    Nurse Pract; 2015 Nov; 40(11):22-6. PubMed ID: 26474199
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing a broader user base for new HCV drug.
    Sekkides O
    Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.
    German P; Mathias A; Brainard D; Kearney BP
    Clin Pharmacokinet; 2016 Nov; 55(11):1337-1351. PubMed ID: 27193156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Chronic Hepatitis C Virus Infection With Crushed Ledipasvir/Sofosbuvir Administered via a Percutaneous Endoscopic Gastrostomy Tube.
    Jindracek L; Stark J
    J Pharm Pract; 2018 Oct; 31(5):522-524. PubMed ID: 28925327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Indications for Harvoni.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of chronic hepatitis C in a kidney transplant patient with only 2 weeks of direct-acting antiviral therapy.
    de Sá Guimarães Cerqueira S; Mesquita MD; Castro RA; Carrola P; Morgado TMPR; Marques P
    Nefrologia (Engl Ed); 2018; 38(6):671-672. PubMed ID: 29871768
    [No Abstract]   [Full Text] [Related]  

  • 30. Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.
    Takata K; Shakado S; Sakamoto K; Fukuda H; Yamauchi R; Fukuda S; Kunimoto H; Umeda K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Sakisaka S
    Clin J Gastroenterol; 2017 Oct; 10(5):459-463. PubMed ID: 28884440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful therapy with Ledipasvir/Sofosbuvir for hepatitis C reactivation in a hematopoietic stem cell transplant recipient.
    Wahba MR; Surapaneni M; Chandrasekar PH
    Leuk Lymphoma; 2016 Nov; 57(11):2693-5. PubMed ID: 26998960
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.
    Najafzadeh M; Andersson K; Shrank WH; Krumme AA; Matlin OS; Brennan T; Avorn J; Choudhry NK
    Ann Intern Med; 2015 Mar; 162(6):407-19. PubMed ID: 25775313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney transplant recipients with hepatitis C virus experienced 100% sustained virologic response at 12 weeks when treated with sofosbuvir-ledipasvir.
    Sise ME
    Hepatology; 2017 Oct; 66(4):1335-1337. PubMed ID: 28650558
    [No Abstract]   [Full Text] [Related]  

  • 34. Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study.
    Abergel A; Asselah T; Metivier S; Kersey K; Jiang D; Mo H; Pang PS; Samuel D; Loustaud-Ratti V
    Lancet Infect Dis; 2016 Apr; 16(4):459-64. PubMed ID: 26803446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
    Enomoto M; Tateishi C; Tsuruta D; Tamori A; Kawada N
    Ann Intern Med; 2018 May; 168(9):678-680. PubMed ID: 29335738
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.
    Gane EJ; Hyland RH; An D; Svarovskaia E; Pang PS; Brainard D; Stedman CA
    Gastroenterology; 2015 Nov; 149(6):1454-1461.e1. PubMed ID: 26261007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.
    Liu CH; Chen YS; Wang SS; Kao JH
    J Formos Med Assoc; 2017 May; 116(5):407-409. PubMed ID: 28089092
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C.
    Fazel Y; Lam B; Golabi P; Younossi Z
    Expert Opin Drug Saf; 2015 Aug; 14(8):1317-26. PubMed ID: 26043900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
    Wyles D; Pockros P; Morelli G; Younes Z; Svarovskaia E; Yang JC; Pang PS; Zhu Y; McHutchison JG; Flamm S; Lawitz E
    Hepatology; 2015 Jun; 61(6):1793-7. PubMed ID: 25846014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States.
    Younossi ZM; Jiang Y; Smith NJ; Stepanova M; Beckerman R
    Hepatology; 2015 May; 61(5):1471-8. PubMed ID: 25706754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.